Institut Jules Bordet is a specialized general hospital and research institute of the Université libre de Bruxelles which specializes in oncology. It is located in Brussels, Belgium.

During the past decade, Institut Jules Bordet-Hopital Universitaire ULB conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Jules Bordet-Hopital Universitaire ULB" #1 collaborator was "Breast International Group" with 1 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator, "German Adjuvant Breast Cancer Group" with 1 trials as a collaborator, "Gruppo Oncologico Italiano di Ricerca Clinica" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Institut Jules Bordet-Hopital Universitaire ULB" are "Breast Cancer" (1 trials), "Breast Cancer Stage II" (1 trials), "Breast Cancer Stage III" (1 trials), "Hypopharyngeal Squamous Cell Carcinoma" (1 trials) and "Non Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Institut Jules Bordet-Hopital Universitaire ULB" in a lesser frequency.

Most popular intervention types in "Institut Jules Bordet-Hopital Universitaire ULB" are "Drug" (2 trials), "Procedure" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel / cyclophosphamide" (1 trials), "Intensity-Modulated Radiation Therapy (IMRT)" (1 trials), "Lorlatinib" (1 trials), "Palbociclib" (1 trials) and "Trans Oral Surgery (TOS)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut Jules Bordet-Hopital Universitaire ULB" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Institut Jules Bordet-Hopital Universitaire ULB". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Institut Jules Bordet-Hopital Universitaire ULB, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institut Jules Bordet-Hopital Universitaire ULB, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".